HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biomarkers and immunomodulation as a treatment option for chronic pain conditions.

Abstract
Inflammation is a well-established contributor to numerous medical conditions, and has discrete roles in disease processes ranging from coronary artery disease and end-stage renal disease to both acute and chronic pain conditions. In some disease processes, inflammatory biomarkers are used clinically to track disease progression and efficacy of treatment, as is seen with complex regional pain syndromes and coronary artery disease. The recognition of such inflammatory biomarkers, and the use of immunomodulating agents for the treatment of chronic pain conditions has become an area of interest, due in part to the successful use of immunomodulating therapy not only for disease progression, but also for symptomatic relief in patients with chronic inflammatory conditions. This article will review this topic and the evidence related to immunomodulation for chronic pain conditions.
AuthorsAnita Gupta, Elizabeth Hewitt, Charlie Oshinsky
JournalPain management (Pain Manag) Vol. 1 Issue 1 Pg. 81-6 (Jan 2011) ISSN: 1758-1869 [Print] England
PMID24654587 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: